@article{8e262b07abf94f13bd2dfad74dee8af1,
title = "Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1",
keywords = "CEND-1, certepetide, iRGD peptide, LSTA1, pharmacokinetics, quantitative radioactivity analysis (QRA), quantitative whole-body autoradiography (QWBA), 413 Veterinary science",
author = "J{\"a}rvel{\"a}inen, {Harri A.} and Christian Schmithals and {von Harten}, Maike and Bianca Kakoschky and Vogl, {Thomas J.} and Stephen Harris and Claire Henson and Gemma Bullen-Clerkson and Albrecht Piiper",
note = "Funding Information: We thank Snorri Thorgeirsson (National Cancer Institute, NIH, Bethesda) for providing the mice transgenic for c-myc and TGFα and Curtis B. Thompson (Cend Therapeutics, Inc.) for insightful discussions on the study. Medical writing support was provided by Dulama Richani, from WriteSource Medical and was funded by DrugCendR Australia Pty Ltd. in accordance with Good Publication Practice (GPP3) guidelines ( http://ismpp.org/gpp3 ). Funding Information: This study was supported by Cend Therapeutics, Inc. and DrugCendR Australia Pty Ltd., and by the Deutsche Krebshilfe [grant number 7011950]. Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
month = mar,
doi = "10.3390/ijms24065700",
language = "English",
volume = "24",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI",
number = "6",
}